Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 20/20 | 0.75 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.75 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.58 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.56 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21939669 | 0.88 | ADORA3 (0.71) | ADORA3 | |
| SCHEMBL21939654 | 0.87 | ADORA3 (0.76) | ADORA3KCNH2ADORA2ASLC6A2SLC6A3 | |
| SCHEMBL22359584 | 0.86 | ADORA3 (0.75) | ADORA3KCNH2ADORA2ASLC6A2SLC6A3 | |
| SCHEMBL20122133 | 0.86 | ADORA3 (0.75) | ADORA3KCNH2ADORA2ASLC6A2SLC6A3 | |
| SCHEMBL23097496 | 0.86 | ADORA3 (0.75) | ADORA3KCNH2ADORA2ASLC6A2SLC6A3 | |
| SCHEMBL23097510 | 0.86 | ADORA3 (0.75) | ADORA3KCNH2ADORA2ASLC6A2SLC6A3 | |
| SCHEMBL21940212 | 0.86 | ADORA3 (0.58) | ADORA3KCNH2ADORA2A | |
| SCHEMBL22359721 | 0.85 | ADORA3 (0.75) | ADORA3KCNH2ADORA2ASLC6A2SLC6A3 | |
| SCHEMBL16774171 | 0.85 | ADORA3 (1.00) | ADORA3KCNH2ADORA2ASLC6A2SLC6A3 | |
| SCHEMBL20122183 | 0.85 | ADORA3 (1.00) | ADORA3KCNH2ADORA2ASLC6A2SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3074398-B1 | A3 ADENOSINE RECEPTOR AGONISTS | US HEALTH (US) | 2021-03-17 | — | — | EP | disclosed |
| WO-2020168274-A1 | TREATMENT OF CHRONIC HEADACHES | SAINT LOUIS UNIVERSITY (US) | 2020-08-20 | — | — | WO | disclosed |
| WO-2020061211-A1 | USE OF HIGHLY-SELECTIVE ADENOSINE 3A RECEPTOR SUBTYPE AGONISTS | SAINT LOUIS UNIVERSITY (US) | 2020-03-26 | — | — | WO | disclosed |